4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-24-110485
Chief Operating Officer bought 5,000 shares at $23.41 ($117,050)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beetham Thomas W. Chief Operating Officer | 2024-09-27 | Purchase | +5,000 | $23.41 | $117,050 | 6,000 | D |
| Open-market purchases · 5,000 sh · avg $23.41 · $117,050 | |||||||
Loading xslF345X05/ownership.xml…